STVN
Stevanato Group SpA
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$21.70
−4.28%Forward multiples
Based on analyst estimates
- P/E forward
- 28.35x
- P/E 2026E
- 30.66x
- P/E 2027E
- 25.48x
- P/E 2028E
- 21.75x
- P/S forward
- 3.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 39.39x
- PEG TTM
- 1.02x
- Price / book
- 3.33x
- Price / sales
- 4.23x
- Price / cash flow
- 20.90x
Enterprise value
- Enterprise value
- $6.3B
- EV / sales
- 4.52x
- EV / EBITDA
- 20.31x
- EV / EBIT
- 28.10x
- Market cap
- $5.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026